welcome to oneFAPvoice
- a positively charged Familial Adenomatous Polyposis community.- join today!
- login
Rofecoxib Reduces Polyp Recurrence in Familial Polyposis.
source: Digestive diseases and sciences
year: 2003
authors: Hallak A, Alon-Baron L, Shamir R, Moshkowitz M, Brazowski E, Halpern Z, Bulvik B, Arber N
summary/abstract:The long-term (mean of 16.4 +/- 4.2 months) efficacy and safety of rofecoxib (a specific COX-2 inhibitor) in maintaining the colon free of polyps in familial polyposis patients was assessed. Eight patients were treated with rofecoxib 25 mg every day. Sigmoidoscopy/colonoscopy was performed at study entry and every six months. At each endoscopy the number, size, and histological grade of all polyps were assessed, and the polyps were removed. The drug was well tolerated with no significant adverse events throughout the study. A highly significant reduction in the rate of polyp formation (70-100%) was observed in all patients from a mean number of 15.1 +/- 11.7 at baseline to 6.0 +/- 5.8 at one year and 1.6 +/- 1.6 at the end of follow-up (P = 0.016 and 0.008, respectively). No patient developed cancer or high-grade adenoma. In conclusion, Long-term use of rofecoxib is well tolerated and effective in inhibiting polyp formation in polyposis patients.
organization: Tel Aviv Sourasky Medical Centerread more
expertly curated content related to this topic
-
Nonsteroidal Anti-Inflammatory Drugs as Anticancer Agents: Mechanistic, Pharmacologic, and Clinical IssuesNumerous experimental, epidemiologic, an...
-
Ureteric Obstruction in Familial Adenomatous Polyposis-Associated Desmoid DiseasePURPOSE : Intra-abdominal desmoid diseas...
-
APC-Associated Polyposis ConditionsCLINICAL CHARACTERISTICS : APC-associate...
-
Colorectal Cancer Chemoprevention: Is This the Future of Colorectal Cancer Prevention?Colorectal cancer (CRC) is presently one...
-
Familial adenomatous polyposis monitoring, Whipple procedure gave my husband more timeWhen he was 15, my husband Jesse underwe...